HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


A Randomized Controlled Trial of Direct Noise Reduction in the ICU Using Overnight Application of In-ear Earplugs or In-ear Earplugs Plus Noise-Canceling Headphones to Reduce the Incidence and Duration of ICU Delirium

Signup
Browse Studies

City:   Winston Salem
State:   North Carolina
Zip Code:   27157
Conditions:   Delirium - Sleep Fragmentation
Purpose:   This study seeks to examine the effects of overnight noise reduction in critically ill patients who are receiving mechanical ventilation. The investigators will randomly place subjects into one of three groups: 1) usual care 2) overnight earplugs 3) overnight earplugs and noise-canceling headphones. The investigators will monitor for safety, and will measure the amount of delirium experienced by subjects, record the amount of sedating and painkilling medicines required, and measure sleep quality during the study, among other information. The investigators will also measure noise levels experienced by patients in each group. The investigators predict that the use of overnight noise reduction will be safe and will reduce the amount of delirium by improving the quality of sleep in critically ill patients.
Study Summary:   Delirium is an acute confusional state defined by fluctuating mental status, inattention, and either disorganized thinking or an altered level of consciousness. Acute delirium is an increasingly recognized problem in intensive care units (ICUs) in the US and worldwide. ICU Delirium has been estimated to occur in as many as 50 to 80 percent of ICU patients. Delirium in the ICU has been associated with worsened clinical outcomes such as prolonged hospitalization and death [1-4]. Although noise has been shown to negatively influence sleep in the ICU, and sleep disturbance is a recognized contributor to ICU delirium[1-2, 4], there is no well-established link between ICU noise levels and the development of ICU delirium. Optimal strategies for the prevention and treatment of ICU delirium are yet to be defined, and this study will focus on a novel noise-reduction approach which has potential to impact both prevention and treatment [5-8]. Findings will be generalizable to other tertiary care medical intensive care units caring for adult patients. Objectives Our multidisciplinary team will evaluate the safety and feasibility of direct noise reduction in the Wake Forest University Baptist Medical Center (WFUBMC) Medical Intensive Care Unit (MICU), and any effect on the incidence of ICU delirium. Methods and Measures Design - Forty-five (45) patients receiving mechanical ventilation will be randomized to receive either passive direct noise reduction (earplugs), both passive and active direct noise reduction (earplugs and noise-canceling headphones), or no direct noise reduction (usual practice). - Ambient noise levels and the reduction in noise accomplished by direct noise reduction will be measured according to standardized audiometric techniques. - Sleep structure, including amount of recovery sleep, will be measured over one night according to standardized polysomnographic (sleep study) techniques - The incidence of delirium will be assessed as well as multiple other endpoints including but not limited to amount of psychoactive medication prescribed and amount of physical restraints required.
Criteria:   Inclusion Criteria: - Adult patients who are admitted to our MICU for at least 24 hours with at least 72 hours' additional expected stay in ICU, and who are mechanically ventilated Exclusion Criteria: - severe to profound hearing loss - baseline use of hearing aids - eardrum perforation - severe cerumen impaction - head or oromaxillofacial trauma - external ventricular drain or intracranial pressure monitoring devices - comatose patients who are deemed by their attending physician as unlikely to awaken within 72 hours - patient status as comfort-measures only - any other contraindication to the use of earplugs or headphones
NCT ID:   NCT01343095
Primary Contact:   Study Director
Matthew C Miles, MD
Wake Forest School of Medicine

Matthew C Miles, MD
Phone: 336-716-4649
Email: mmiles@wakehealth.edu
Backup Contact:   Email: dhite@wakehealth.edu
Robert D Hite, MD
Phone: 336-716-4649
Location Contact:   Winston Salem, North Carolina 27157
United States

Matthew C Miles, MD
Phone: 336-716-4649
Email: mmiles@wakehealth.edu

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   May 22, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"
First Name:  
Last Name:  
Email Address:  
Confirm Email:    
Daytime Phone (eg. 555-555-5555):  
City:  
State:
Zip Code:    
Best Time to Call:  
Questions/Comments:  
  • NEARBY STUDIES

Within 25 Miles

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Winston Salem NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - High Point NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Greensboro NC

Type 2 Diabetes - High Point NC

Arthritis - Greensboro NC

High Triglycerides - High Point NC

Effects of Cigarette Mentholation on Brain Nicotine - Winston Salem NC

Restless Legs Syndrome (RLS) - Winston Salem NC

Irritable Bowel Syndrome (with diarrhea) - Winston Salem NC

Irritable Bowel Syndrome (with diarrhea) - High Point NC

Irritable Bowel Syndrome (with diarrhea) - Greensboro NC

Diabetics with High Triglycerides - High Point NC

Gout - Winston Salem NC

Low Back Pain and Constipation - Winston Salem NC

Within 50 Miles

Arthritis - Mooresville NC

Low Back Pain and Constipation - Elkin NC

Gout - Greensboro NC

Within 100 Miles

Smoking - Durham NC

Ulcerative Colitis - Raleigh NC

Arthritis and Heart Disease - Raleigh NC

COPD (Chronic Obstructive Pulmonary Disease) - Raleigh NC

Asthma - Raleigh NC

Investigational Contraceptive Gel - Raleigh NC

Ulcerative Proctitis or Proctosigmoiditis - Boone NC

Crohn's Disease - Raleigh NC

Nocturia - Raleigh NC

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation - Durham NC

Gout - Raleigh NC

Chronic Constipation - Raleigh NC

Smoke Cessation Study (Stop Smoking) - Raleigh NC

Gout - Raleigh NC

Gout - Raleigh NC

Intolerance to Gout Medication - Raleigh NC

Irritable Bowel Syndrome w/ Diarrhea - Raleigh NC

Migraine Headaches in Teens and Adolescents - Raleigh NC

Bladder Pain (Interstitial Cystitis) - Raleigh NC

Diabetic Gastroparesis - Raleigh NC

Irritable Bowel Syndrome with Diarrhea - Raleigh NC

Bowel Prep - Raleigh NC

High LDL (Cholesterol) - Raleigh NC

Post-Shingles Pain (Postherpetic Neuralgia) - Raleigh NC

Rosacea - Raleigh NC

Endometriosis - Raleigh NC

Melanoma Vaccine - Raleigh NC

Narcolepsy - Raleigh NC

Anal Fissures - Raleigh NC

Celiac Disease - Raleigh NC

Chronic Cough - Raleigh NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Cary NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Raleigh NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Boone NC

Rheumatoid Arthritis - Raleigh NC

Crohn's Disease - Durham NC

Hypertriglyceridemia - Raleigh NC

Fibromyalgia - Raleigh NC

Warts - Raleigh NC

Osteoarthritis of the Knee - Raleigh NC

Arthritis - Danville VA

Gastroparesis - Raleigh NC

Irritable Bowel Syndrome with Constipation - Raleigh NC

Gout - Rock Hill SC

Gout - Shelby NC1

Post-Shingle Pain - Raleigh NC

Type II Diabetes with Cardio Risk - Raleigh NC

Type II Diabetes - Raleigh NC

Postherpetic Neuralgia (Post-Shingles Pain) - Hickory NC

Excessive Daytime Sleepiness with Narcolepsy - Raleigh NC

Restless Legs Syndrome (RLS) - Hickory NC

Restless Legs Syndrome (RLS) - Raleigh NC

Male Smokers - Durham NC

Irritable Bowel Syndrome (with diarrhea) - Raleigh NC

Irritable Bowel Syndrome (with diarrhea) - Raleigh NC

Irritable Bowel Syndrome (with diarrhea) - Charlotte NC

Irritable Bowel Syndrome (with diarrhea) - Charlotte NC

Irritable Bowel Syndrome (with diarrhea) - Hickory NC

Irritable Bowel Syndrome (with diarrhea) - Fort Mill SC

High Cholesterol and Statin Therapy - Raleigh NC

Arthritis - Rock Hill SC

Lower Back Pain Radiating to the Legs - Raleigh NC

Multiple Sclerosis - Chapel Hill NC

Chronic Constipation - Raleigh NC

Acne Rosacea - Raleigh NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Chapel Hill NC

Low Back Pain and Constipation - Danville VA

Irritable Bowel Syndrome (with diarrhea) - Durham NC

Irritable Bowel Syndrome (with diarrhea) - Charlotte NC

Sexual Issues for Women - Raleigh NC

Chronic Idiopathic Constipation - Raleigh NC

Arthritis - Raleigh NC

Uncontrolled Angina (Adult Stem Cell Research) - Charlotte NC

Uncontrolled Angina (Adult Stem Cell Research) - Durham NC

COPD (Emphysema and Chronic Bronchitis) - Fort Mill SC

Rabies Vaccine - Raleigh NC

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.